HH BIOTECHNOLOGY HOLDINGS CO
company.status.inactiveCIK 828878fmd_0WXNBFR26PWR5E8T191JVMNHA5Finance, Insurance and Real Estate · Real EstateTemplate: Real estate
Coverage: Jan 01, 2010 to Sep 30, 2016, 26 periods
Latest annual · FY2015
Millions- Total revenues
- 8
- Gross profit
- 2
- Operating income
- 3
- Net income
- 2
- Free cash flow
- 4
Latest quarter · Q3 FY2016
Millions- Total revenues
- 2
- Gross profit
- 1
- Operating income
- 2
- Net income
- 1
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2012 to FY2015
- +2.8%
- Revenue, 5 yearsFY2010 to FY2015
- +1.6%
- Net income, 5 yearsFY2010 to FY2015
- n/m
HH BIOTECHNOLOGY HOLDINGS CO financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2015 | FY2014 | Change | Source |
|---|---|---|---|---|
| Revenue | $8 million | $8 million | 0% | 10-K 2016-04-14 · proof |
| Gross profit | $2.4 million | $1.7 million | +39.6% | 10-K 2016-04-14 · proof |
| Operating income | $3.1 million | -$2.8 million | 10-K 2016-04-14 · proof | |
| Net income | $2.4 million | -$4.3 million | 10-K 2016-04-14 · proof | |
| Cash from operating activities | $3.6 million | $1.7 million | +112% | 10-K 2016-04-14 · proof |
| Free cash flow | $3.5 million | $1.7 million | +109.6% | 10-K 2016-04-14 · proof |
| Total assets | $46.5 million | $54 million | -13.9% | 10-K 2016-04-14 · proof |
| Total liabilities | $18.1 million | $34.8 million | -48.1% | 10-Q 2016-11-14 · proof |
| Cash and cash equivalents | $9.8 million | $8.8 million | +11.6% | 10-K 2016-04-14 · proof |
- What was HH BIOTECHNOLOGY HOLDINGS CO's revenue in fiscal 2015?
- HH BIOTECHNOLOGY HOLDINGS CO reported revenue of $8 million for fiscal 2015 (the year ended Dec 31, 2015), against $8 million the year before (0%). Source: the 10-K filed with the SEC on Apr 14, 2016. SEC
- What was HH BIOTECHNOLOGY HOLDINGS CO's gross profit in fiscal 2015?
- HH BIOTECHNOLOGY HOLDINGS CO reported gross profit of $2.4 million for fiscal 2015 (the year ended Dec 31, 2015), against $1.7 million the year before (+39.6%). Source: the 10-K filed with the SEC on Apr 14, 2016. SEC
- What was HH BIOTECHNOLOGY HOLDINGS CO's operating income in fiscal 2015?
- HH BIOTECHNOLOGY HOLDINGS CO reported operating income of $3.1 million for fiscal 2015 (the year ended Dec 31, 2015), against -$2.8 million the year before. Source: the 10-K filed with the SEC on Apr 14, 2016. SEC
- What was HH BIOTECHNOLOGY HOLDINGS CO's net income in fiscal 2015?
- HH BIOTECHNOLOGY HOLDINGS CO reported net income of $2.4 million for fiscal 2015 (the year ended Dec 31, 2015), against -$4.3 million the year before. Source: the 10-K filed with the SEC on Apr 14, 2016. SEC
- What was HH BIOTECHNOLOGY HOLDINGS CO's cash from operating activities in fiscal 2015?
- HH BIOTECHNOLOGY HOLDINGS CO reported cash from operating activities of $3.6 million for fiscal 2015 (the year ended Dec 31, 2015), against $1.7 million the year before (+112%). Source: the 10-K filed with the SEC on Apr 14, 2016. SEC
- What was HH BIOTECHNOLOGY HOLDINGS CO's free cash flow in fiscal 2015?
- HH BIOTECHNOLOGY HOLDINGS CO reported free cash flow of $3.5 million for fiscal 2015 (the year ended Dec 31, 2015), against $1.7 million the year before (+109.6%). Source: the 10-K filed with the SEC on Apr 14, 2016. SEC
- What are HH BIOTECHNOLOGY HOLDINGS CO's total assets?
- As of Dec 31, 2015, HH BIOTECHNOLOGY HOLDINGS CO reported total assets of $46.5 million, against $54 million a year earlier (-13.9%). Source: the 10-K filed with the SEC on Apr 14, 2016. SEC
- What are HH BIOTECHNOLOGY HOLDINGS CO's total liabilities?
- As of Dec 31, 2015, HH BIOTECHNOLOGY HOLDINGS CO reported total liabilities of $18.1 million, against $34.8 million a year earlier (-48.1%). Source: the 10-Q filed with the SEC on Nov 14, 2016 (restated). SEC
- What are HH BIOTECHNOLOGY HOLDINGS CO's cash and cash equivalents?
- As of Dec 31, 2015, HH BIOTECHNOLOGY HOLDINGS CO reported cash and cash equivalents of $9.8 million, against $8.8 million a year earlier (+11.6%). Source: the 10-K filed with the SEC on Apr 14, 2016. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:828878&period_type=annual&limit=5"Information only, not investment advice.